Outlook Therapeutics, Inc. (OTLK): 10-Q filed Aug 18, 2026

Form type

10-Q

Filing date

Aug 18, 2026

Accession number

0001104659-26-098415

Filer

Outlook Therapeutics, Inc. (CIK 1649989)